Literature DB >> 15162989

Radionuclide imaging of the thyroid gland: patterns, pearls, and pitfalls.

Joel R Smith1, Elizabeth Oates.   

Abstract

Optimal thyroid scintigraphy requires an understanding of 1) the embryology, anatomy, and physiology of the thyroid gland; and 2) the properties of the 2 common imaging agents, technetium-99m pertechnetate (Tc-99m) and radioiodine (1-123). The normal gland has a characteristic scintigraphic pattern with these tracers and its uptake can be quantified with 1-123. Thyroid diseases often produce characteristic abnormal patterns. These abnormal patterns could be described as diffuse or focal, homogeneous or heterogeneous, increased or decreased. "Extrathyroidal" localization can be seen with esophageal activity, ectopic tissue, thyroglossal duct cyst, and substernal goiter. Thyroid scintigraphy of neonates, as a follow up to abnormal blood screening, demonstrates typical etiologic patterns. The first step in evaluating a patient with suspected thyroid disease is correlating the normal or abnormal scintigraphic pattern with available biochemical data, clinical history, and physical examination. By integrating the interpretive and technical "pearls" and "pitfalls" outlined in this article, the radiologist can be more confident in establishing a proper diagnosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15162989     DOI: 10.1097/01.rlu.0000114530.12565.5b

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  13 in total

1.  Concurrent sublingual thyroid and thyroglossal cyst with functioning thyroid tissue in the absence of an orthotopic thyroid gland.

Authors:  Kuruva Manohar; Anish Bhattacharya; Raghava Kashyap; Koramadai Karuppusamy Kamaleshwaran; Bhagwant Rai Mittal
Journal:  Jpn J Radiol       Date:  2010-08-27       Impact factor: 2.374

2.  Dual thyroid ectopia with graves' disease: a case report and a review of the literature.

Authors:  Teik Hin Tan; Boon Nang Lee; Siti Zarina Amir Hassan; Ewe Seng Ch'ng; Zanariah Hussein
Journal:  Nucl Med Mol Imaging       Date:  2012-08-09

3.  High Prevalence of Thyroid Disease and Role of Salivary Gland Scintigraphy in Patients with Xerostomia.

Authors:  Ji-Hoon Jung; Chang-Hee Lee; Seung Hyun Son; Ju Hye Jeong; Shin Young Jeong; Sang-Woo Lee; Jaetae Lee; Byeong-Cheol Ahn
Journal:  Nucl Med Mol Imaging       Date:  2016-11-24

4.  Intrathoracic Goiter Visualized on iodine-123 and technetium-99m Single-Photon Emission Computed Tomography/Computed Tomography.

Authors:  Mattias Hedegaard Kristensen; Jan Abrahamsen; Henrik Holm Thomsen
Journal:  World J Nucl Med       Date:  2021-11-01

Review 5.  Substernal goiter: an unusual cause of respiratory failure after coronary artery bypass grafting.

Authors:  Kerim Cagli; Mahmut Mustafa Ulas; Mustafa Hizarci; Erol Sener
Journal:  Tex Heart Inst J       Date:  2005

6.  Radioimmunoscintigraphy of pancreatic cancer in tumor-bearing athymic nude mice using (99m)technetium-labeled anti-KL-6/MUC1 antibody.

Authors:  Kenji Matsumura; Ichiro Niki; Hui Tian; Masahisa Takuma; Norio Hongo; Shunro Matsumoto; Hiromu Mori
Journal:  Radiat Med       Date:  2008-04

7.  Serum Free T3 to Free T4 Ratio as a Useful Indicator for Differentiating Destruction Induced Thyrotoxicosis from Graves' Disease.

Authors:  Suman Baral; Pradeep Krishna Shrestha; Vivek Pant
Journal:  J Clin Diagn Res       Date:  2017-07-01

8.  Hyperfunction thyroid nodules: their risk for becoming or being associated with thyroid cancers.

Authors:  Eun Sun Lee; Ji-Hoon Kim; Dong Gyu Na; Jin Chul Paeng; Hye Sook Min; Seung Hong Choi; Chul Ho Sohn; Ki-Hyun Chang
Journal:  Korean J Radiol       Date:  2013-07-17       Impact factor: 3.500

9.  Scintigraphic evaluation of thyroid pyramidal lobe.

Authors:  Arzu Cengiz; Hatice Sakı; Yakup Yürekli
Journal:  Mol Imaging Radionucl Ther       Date:  2013-08-01

10.  Oesophageal conduit - a cause of diffuse mediastinal uptake on thyroid scintigraphy.

Authors:  Luke I Sonoda; Kottekkattu K Balan
Journal:  Mol Imaging Radionucl Ther       Date:  2013-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.